Introduction
|
 |
An
Emptying Quiver: Antimicrobial Drugs and Resistance, J.T.
Weber and P. Courvalin |
Perspectives
|
|
Antimicrobial
Resistance Determinants and Future Control, S. Harbarth and
M.H. Samore |
|
Hidden
Epidemic of Macrolide-resistant Pneumococci, K.P. Klugman
et al. |
Research
|
|
Integrating
Escherichia coli Antimicrobial Susceptibility Data from Multiple
Surveillance Programs, J.M. Stelling et al. |
|
Nonprescribed
Antimicrobial Drugs in Latino Community, South Carolina, A.G.
Mainous et al. |
|
Community-associated
Methicillin-resistant Staphylococcus aureus in Hospital Nursery
and Maternity Units, S. Bratu et al. |
|
Methicillin-resistant
Staphylococcus aureus and Vancomycin-resistant Enterococci
in Rural Communities, Western United States, K.B. Stevenson
et al. |
|
Relative
Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae,
C.N. Johnson et al. |
|
Global
Spread of Vancomycin-resistant Enterococcus faecium from Distinct
Nosocomial Genetic Complex, R.J.L. Willems et al. |
|
Methicillin-resistant–Staphylococcus
aureus Hospitalizations, United States, M.J. Kuehnert
et al. |
|
International
Salmonella Typhimurium DT104 Infections, 1992–2001,
M. Helms et al. |
|
Emergence
and Spread of Streptococcus pneumoniae with erm(B)
and mef(A) Resistance, D.J. Farrell et al. |
|
pVir
and Bloody Diarrhea in Campylobacter jejuni Enteritis,
D.M. Tracz et al. |
|
Impact
of Statewide Program To Promote Appropriate Antimicrobial Drug Use,
E.A. Belongia et al. |
|
Community-associated
Methicillin-resistant Staphylococcus aureus, Canada,
M.R. Mulvey et al. |
|
Trypanosomiasis
Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001,
J. Pepin and B. Mpia |
|
Fluoroquinolone-resistant
Escherichia coli Carriage in Long-Term Care Facility,
J.N. Maslow et al. |
|
Clinician
Knowledge and Beliefs after Statewide Program to Promote Appropriate
Antimicrobial Drug Use, K.M. Kiang et al. |
|
Community
Prescribing and Resistant Streptococcus pneumoniae,
G. Barkai et al. |
Dispatches
|
|
Methicillin-resistant
Staphylococcus aureus in Community-acquired Skin Infections,
G.J. Moran et al. |
|
Free-living
Canada Geese and Antimicrobial Resistance, D. Cole et al. |
|
Macrolide-
and Telithromycin-resistant Streptococcus pyogenes, Belgium,
1999–2003, S. Malhotra-Kumar et al. |
|
Hospitalization
and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002,
J.K. Varma et al. |
|
Cephalosporin
and Ciprofloxacin Resistance in Salmonella, Taiwan,
J.-J. Yan et al. |
|
Global
Spread of Multiple Aminoglycoside Resistance Genes, K. Yamane
et al. |
|
armA
and Aminoglycoside Resistance in Escherichia coli,
B. González-Zorn et al. |
|
Rifampin
Resistance in Tuberculosis Outbreak, London, England, C. Jenkins
et al. |
|
Tuberculosis
due to Resistant Haarlem Strain, Tunisia, H. Mardassi et al. |
|
Community-associated
Methicillin-resistant Staphylococcus aureus, Switzerland,
S. Harbarth et al. |
|
Community-associated
Methicillin-resistant Staphylococcus aureus in Pediatric Patients,
T.J. Ochoa et al. |
|
Erythromycin-nonsusceptible
Streptococcus pneumoniae in Children, 1999–2001, M.C.
McEllistrem et al. |
|
Community-acquired
Methicillin-resistant Staphylococcus aureus, Uruguay,
X.X. Ma et al. |
|
Rifampin-resistant
Meningococcal Disease, J. Rainbow et al. |
Letters
|
|
Diversification
in Salmonella Typhimurium DT104, J. Threlfall et al. |
|
Extended-spectrum
β-Lactamase-producing Flora in Healthy Persons, C. Rodrigues
et al. |
|
Measuring
Impact of Antimicrobial Resistance, M.-C. Roghmann et al. |
|
Antimicrobial
Resistance in Campylobacter, (Responses) |
|
Quinolone
Safety and Efficacy, (Responses) |
News and Notes
|
|
Cover
Drugs,
Microbes, and Antimicrobial Resistance, P. Potter |
